← Full daily brief

Mass Tort brief

Mass Tort Briefing: Abbott Preterm Formula Deal and Social Media Addiction Trials

Abbott agrees to a $670M formula deal, Meta faces federal youth addiction trials, real estate commissions hit final approval, and silicosis verdicts expand.

Signalpoint TeamBrief

Mass Tort

Abbott bought out its biggest formula liability risk — capping financial damage after appellate courts refused to shield it from catastrophic jury verdicts.

BackgroundSpecialty formulas nourish premature infants in intensive care, but parents allege manufacturers failed to warn that cow's milk formulas increase life-threatening bowel disease risks. Thousands of personal injury lawsuits hit formula makers following major jury verdicts.

Points
  1. Abbott agreed to compromise claims handled by three key law firms after appellate courts denied post-trial relief in Missouri state court.
  2. The resolution covers about 2,000 cases while allowing Abbott to deny liability and preserve formula sales in hospital neonatal units.
  3. Approximately 1,700 lawsuits remain pending across state courts and federal multidistrict litigation, maintaining industry-wide defense costs for remaining trials.

Mass Tort

State AGs are testing Meta's primary legal defense in court — attempting to establish that algorithmic product design constitutes an actionable product defect.

BackgroundMultidistrict litigation consolidates thousands of personal injury and municipal lawsuits alleging algorithmic feeds cause severe youth mental health injuries. Plaintiffs argue tech companies prioritized user engagement and ad revenue over child safety.

Points
  1. An eight-person advisory jury is hearing evidence alongside US District Judge Yvonne Gonzalez Rogers to guide valuation for over 3,100 consolidated claims.
  2. State prosecutors presented internal communications showing Meta executives disregarded warnings from safety researchers about algorithmic harm to teenagers.
  3. The trial serves as the primary federal test case for school districts, families, and state enforcement actions seeking product liability damages.

Mass Tort

A key state bellwether suit dissolved before trial — depriving plaintiffs of an early trial verdict and delaying valuation benchmarks for California claims.

BackgroundBellwether trials serve as test cases in consolidated mass tort proceedings to help both sides gauge jury reactions and establish settlement benchmarks. In California state court, thousands of social media harm claims were grouped under judicial management.

Points
  1. The voluntary dismissal in Los Angeles Superior Court occurred right before trial jury selection in the state-coordinated proceeding JCCP 5255.
  2. Co-defendant TikTok previously settled the minor plaintiff's claims out of court, leaving the remaining tech giants without a trial test.
  3. Two remaining state-court bellwether trials stay scheduled for October, giving social media companies additional time to refine defense strategies.

Mass Tort

The Eighth Circuit locked in real estate's new commission model — ending industry legal exposure while permanently unbundling agent compensation fees.

BackgroundHome sellers sued real estate brokerages alleging industry rules forced sellers to offer non-negotiable buyer broker commissions that artificially inflated real estate transaction costs. The settlement reshaped how real estate agents negotiate compensation across the country.

Points
  1. The appellate panel rejected challenges from seven objector groups who argued the compromise provided inadequate cash recovery for past home sellers.
  2. The decision cements nationwide prohibitions against listing services mandating seller-paid buyer broker compensation offers.
  3. Participating brokerages and franchisors receive complete antitrust releases, protecting the industry from ongoing private treble-damages class actions.

Mass Tort

Mass Tort

Unlock the full brief

Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.

Or read free in the appDownload on the App Store